Effect of cicletanine on the nitric oxide pathway in human umbilical vein endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 2, 2001, Pages 174-182

  Akamatsu, Naoaki ^a   Sawada, Shohei ^a   Komatsu, Sumio ^a   Tamagaki, Toshiyuki ^a   Hiranuma, Osamu ^a   Kawahara, Takeshi ^a   Tsuda, Yutaka ^a   Kono, Yoshihito ^a   Higaki, Tadashi ^a   Tada, Yusuke ^a   Yamasaki, Seiki ^a   Imamura, Hitoshi ^a   Sato, Toshiyuki ^a   Tsuji, Hajime ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cicletanine; Cyclic GMP; Human endothelial cell; Nitric oxide; Prostacyclin

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; CALCIUM ION; CICLETANINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; DIURETIC AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; N(G) METHYLARGININE; NITRIC OXIDE; PROSTACYCLIN;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

ANTIHYPERTENSIVE AGENTS; CALCIUM; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR FLUID; NITRIC OXIDE; PYRIDINES; UMBILICAL VEINS;

EID: 0034922718     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200108000-00002     Document Type: Article

References (31)

1. Vascular remodeling and antihypertensive therapy: The example of cicletanine
2. Study of the effects of cicletanine on prostanoids
3. 2+ level and contraction in vascular smooth muscle
4. Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by "diuretic-antihypertensive" drugs
5. 2 synthesis caused by cicletanine in patients with essential hypertension
6. Comparative studies of angiotensin converting enzyme inhibitors with or without the SH-radical
7. 2+ kinetics
8. Effect of probucol on intracellular pH and proliferation of human vascular endothelial cells
9. 2) synthesis in human vascular endothelial cells
10. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice
11. Culture of human endothelial cells derived from umbilical veins
12. New cytoplasmic components in arterial endothelia
13. Prostacyclin generation by cultured human vascular endothelial cells with reference to angiotensin I-converting enzyme
14. 2+ indicators with greatly improved fluorescence properties
15. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin
16. Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells
17. 2 in bradykinin-induced PGI2 synthesis by human vascular endothelial cells
18. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in cerebellum of conscious rats
19. ++-regulated protein kinases and relationship to vasorelaxation by cicletanine
20. Long-term cicletanine treatment protects endothelial cell function against hypertension in Dahl salt-sensitive rats
21. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells
22. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle
23. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase
24. Effect of cyclic GMP and sulfhydryl on prostacyclin production by human vascular endothelial cells
25. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes
26. Endothelial nitric oxide synthase gene transfer enhances dilation of newborn piglet pulmonary arteries
27. 2+) influx into human endothelial cells via P2X4 purinoceptors
28. ++ from a non-mitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate
29. Inositol 1,4,5-trisphosphate release calcium from skinned cultured smooth muscle cells